Table 4. Treatment plan of study participants.
| Variable | Frequency |
|---|---|
|
Chemotherapy indication Adjuvant Neoadjuvant Palliative |
25 (22.1) 79 (69.9) 9 (8.0) |
|
Chemotherapy (first-line regimen) Anthracycline Cyclophosphamide, Methotrexate, Fluorouracil Taxane |
111 (98.2) 1 (0.9) 1 (0.9) |
|
Chemotherapy (second-line regimen) (n = 40) Platinum Taxane Platinum and taxane |
1 (2.4) 33 (80.6) 6 (14.6) |